Multi-institution Phase I/Ib study of ibrutinib with ABT-199 in relapsed/refractory mantle cell lymphoma

IRB/UVA Tracking #
17983
Contact First Name

Erica Stallard

Contact Email
Phase
I
Primary purpose
Treatment
Cancer PI
Craig Portell
Status
OPEN TO ACCRUAL